Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
04/2007
04/25/2007CN1951906A L-dopa methyl ester hydrochloride synthesis and purification method
04/25/2007CN1951905A Clean method for producing high-purity laminine
04/25/2007CN1312135C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
04/25/2007CN1312125C Amino alcohol derivative, addition salt thereof, and immunosuppressant
04/25/2007CN1312118C Process for synthesizing carnitine
04/25/2007CN1312117C Extraction technology of gamma amino butyric acid in folium mori
04/25/2007CN1312116C Calcium acceptor active compound
04/25/2007CN1312106C Preparation method of water soluble curcumin composition salt
04/24/2007US7208622 Methods for producing nateglinide crystals
04/24/2007US7208607 Reaction of 2-bromophenylalaninate with diisopropylethylamine and (2R)-2-bromopropionyl chloride and reaction of product with ethyl (2S)-2-aminopentanoate, triethylamine and acetonitrile, and hydrogenation of product; new process uses readily obtainable starting materials
04/24/2007US7208178 For facilitating the delivery of active agents, such as insulin, to a target
04/24/2007CA2289472C Excitatory amino acid receptor modulators
04/19/2007WO2007042363A1 Feedstuff additive containing l-lysine
04/19/2007WO2006088786A3 Compounds and uses thereof
04/19/2007US20070088174 Synthesis of phenoxyacetic acid derivatives
04/19/2007US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
04/18/2007CN1950329A Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosi
04/18/2007CN1950328A Phenyl indan derivatives
04/18/2007CN1950327A Method of purifying amino acid
04/18/2007CN1311122C Method for delivering biologically active substances
04/18/2007CN1310873C Production process of high-purity DL-lysine
04/18/2007CN1310872C Mono- and disubstituted 3-propyl gamma-aminobutyric acids
04/17/2007US7205433 Crystal of amino acid ester salt and process for producing the same
04/17/2007US7205401 Separation of such enantiomers with non-chromatographic resin bed separations of three separation stages or less; efficiency; chiral purity
04/17/2007US7205336 β-secretase inhibitors
04/17/2007US7205290 Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use
04/17/2007US7205273 Fusogenic liposomes
04/17/2007CA2308721C Radio-opaque polymer biomaterials
04/17/2007CA2277151C Synthesis of acyclic nucleoside derivatives
04/17/2007CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof
04/12/2007WO2007039522A2 Process for esterification of an organic acid
04/12/2007WO2007009055A3 Ester prodrugs of prostratin and related phorbol compounds
04/12/2007WO2005117526A3 An improved process for the purification of gabapentin
04/12/2007US20070083052 Process for synthesis of perindopril and pharmaceutically acceptable salts thereof.
04/12/2007US20070082951 protamine-mimetic compounds; calixarenes substituted with amino acids bearing salifiable amino groups; In post-surgical protocols to prevent thromboembolism, clotting and thrombi; to prevent clotting in dialysis circuits; side effects reduction; minimize the risk of hemorrhage in dialysed patients
04/12/2007US20070081941 F-18 Labeled Amino Acid Analogs
04/11/2007EP1073623B1 Substituted amino acids as erythropoietin mimetics
04/11/2007CN1944397A Process for preparing EDTA disodium salt
04/11/2007CN1309730C Powder trace element, method and device for making same
04/11/2007CN1309703C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
04/11/2007CN1309702C Synthesis method of kynureninase specificity inhibitor-L-methoxybenzoyl alanine
04/11/2007CN1309381C Nordihydroguaiaretic derivatives for use in treatment of tumors
04/10/2007US7202364 ortho-substituted with a fused (hetero)arylamino group, e.g., carboxymethyl 2-(6-chloro-5-indanylamino)phenylacetate; treatment of COX-2 dependent disorders including rheumatoid arthritis, osteoarthritis, dysmenorrhea, pain, tumors or inflammation
04/10/2007US7202242 Substituted 1 and 2-naphthol Mannich bases
04/10/2007CA2262367C Anti-bacterial amine derivatives
04/10/2007CA2152980C Process for reacting a perfluoroalkyl iodide with an olefinic compound
04/10/2007CA2133991C T-butyl cascade polymers
04/05/2007US20070078183 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
04/05/2007US20070078139 Phosphodiesterase 4 inhibitors
04/04/2007EP1768952A2 Preparation of beta-amino acids having affinity for the alpha-2-delta protein
04/04/2007EP1768950A2 Process for making (s)-pregabalin
04/04/2007EP1554235A4 Process for synthesizing l-y-methylene glutamic acid and analogs
04/04/2007EP1551793A4 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
04/04/2007EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
04/04/2007CN1942428A CETP inhibitors
04/04/2007CN1942427A Indene derivatives and process for the preparation thereof
04/04/2007CN1939895A Compound, composition and method for preventing from neurodegeneration in injury of central nervous system
04/04/2007CN1939894A Process for the coupling of benzylamines and halogenated aromates
04/04/2007CN1939893A Lysine-ketoprofen and its production
04/04/2007CN1939892A Process for preparing methyl 4-aminomethylbenzoate
04/03/2007US7199266 Cationic ion exchanging of gabapentin hydrochloride
04/03/2007US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
04/03/2007US7199261 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives
04/03/2007US7199141 Such as 1-(aminomethyl)cyclohexane-acetic acid-2-methoxy-4-[(1E)-3-[4-(nitrooxy)butoxy]-3-oxy-1-propenyl]phenyl hydrochloride ester; reduced side effects
04/03/2007CA2172519C Method of resolution of two enantiomers by crystallysation
03/2007
03/29/2007WO2007035890A1 An asymmetric synthesis of ( s ) - ( + ) -3- (aminomethyl) -5-methylhexanoic acid
03/29/2007WO2007035789A1 Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the new synthesis of (s)-pregabalin
03/29/2007WO2007034909A1 Process for production of (3r,5r)-7-amino-3,5-dihydroxyheptanoic acid derivative
03/29/2007WO2007034812A1 Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier
03/29/2007WO2007034673A1 Process for producing 5-aminolevulinic acid hydrochloride
03/29/2007WO2007034064A1 Continuous synthesis of an $g(a)-amino acid from a cyanhydrin of $g(a)-amino acid without the isolation of intermediate products
03/29/2007WO2007017610A3 Cosmetic composition comprising at least one fatty-chain polylysine, which is intended to improve the surface state of keratin fibres
03/29/2007WO2007010516A3 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field
03/29/2007WO2007010514A3 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field
03/29/2007WO2006020652A3 Orally administered small peptides synergize statin activity
03/29/2007US20070073085 Method for the preparation of pregabalin and salts thereof
03/29/2007US20070073004 Hyperbranched (pamam) polymers via a one pot process
03/29/2007US20070071665 Use of a derivative of aspartic acid as a collector in froth flotation processes
03/29/2007DE102005046344A1 Verfahren zur Kupplung von Benzylaminen mit Halogenaromaten A method for coupling of benzylamines with haloaromatics
03/29/2007DE102005046343A1 Preparation of 4-(aminomethyl)benzoic acid methylester, useful as pharmaceutical intermediates, comprises esterifying 4-aminomethylbenzoic acid with methanol in the presence of hydrochloric acid, solvent and separating organic phase
03/29/2007CA2619472A1 Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the new synthesis of (s)-pregabalin
03/29/2007CA2618603A1 Method for producing 5-aminolevulinic acid hydrochloride
03/28/2007EP1767521A1 L-ornithine-citric acid salt crystal
03/28/2007EP1767199A2 Methods and compositions for treatment of cancer pain
03/28/2007EP1765835A1 Process for the preparation of amino acids useful in the preparation of peptide receptor modulators
03/28/2007EP1765812A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
03/28/2007EP1765768A1 Substituted acids for the treatment of respiratory diseases
03/28/2007EP1765767A1 Process for the preparation of gabapentin
03/28/2007EP1138745B1 Organic electroluminescent element
03/28/2007CN1938343A Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
03/28/2007CN1938264A Acid addition salts of 5-aminolevulinic acid or its derivatives
03/28/2007CN1938263A Process for preparing amino acids using the amidocarbonylation reaction
03/28/2007CN1938244A Fluoridation method
03/28/2007CN1935787A Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
03/27/2007US7196214 The synthesis of charge transfer compounds of an aminobiphenyl circumventing using toxic 4-aminobiphenyl by reacting a 4-bromoaniline with a halo, carboxyarylene and using traditional chemistry, Ullman condensation , Suzuki coupling; high strength;improved image deletion under high temperature/humidity
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/27/2007US7196084 Cdc25 phosphatase inhibitors
03/27/2007US7195772 Amino-acid iodine complex
03/27/2007CA2180841C 1-aminoindan derivatives and compositions thereof
03/22/2007WO2007032409A1 Method for synthesis of keto acid or amino acid by hydration of acethylene compound
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 215